| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Diamedica Therapeutics Inc. (DMAC) has 5 insiders with recent SEC Form 4 filings, including 24 buys and 0 sells. DMAC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 8.83M | $58.82M | - | |
| Other | 450.0K | $3.00M | - | |
| Dir | 398.6K | $2.66M | - | |
| Dir | 97.9K | $652.8K | - | |
| Dir | 48.0K | $319.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 25, 2025 | Stahlberg Jan82 | 10% Owner | Buy | 1,061,277 | $7.19 | $7,631,469.24 | +1.8% | -7.9% | - | |
| Aug 27, 2025 | Stahlberg Jan82 | 10% Owner | Buy | 1,000,000 | $5.96 | $5,958,106.80 | +1.5% | +51.0% | - | |
| Jul 23, 2025 | Von Koch Thomas68 | 10% Owner | Buy | 2,857,142 | $3.50 | $9,999,997.00 | +51.7% | +28.5% | +32.4% | |
| Jul 23, 2025 | Stahlberg Jan82 | 10% Owner | Buy | 1,542,857 | $3.50 | $5,399,999.50 | +29.5% | +28.5% | +32.4% | |
| Jul 23, 2025 | Jacinto Richard II | 10% Owner | Buy | 400,000 | $3.50 | $1,400,000.00 | +8.8% | +28.5% | +32.4% | |
| Jun 28, 2024 | Stahlberg Jan82 | 10% Owner | Buy | 1,200,000 | $2.50 | $3,000,000.00 | +29.8% | +45.8% | +30.2% | |
| Jun 28, 2024 | Von Koch Thomas68 | 10% Owner | Buy | 1,200,000 | $2.50 | $3,000,000.00 | +27.7% | +45.8% | +30.2% | |
| Nov 16, 2023 | Wambeke David J.67 | Chief Business Officer | Buy | 20,000 | $2.46 | $49,200.00 | +3.9% | +23.9% | +68.5% | |
| Jun 23, 2023 | Pauls Dietrich John49 | President And CEO | Buy | 12,787 | $3.91 | $49,997.17 | +22.9% | -29.4% | -49.2% | |
| Jun 23, 2023 | Kellen Scott | CFO And Secretary | Buy | 10,000 | $3.91 | $39,100.00 | +44.9% | -29.4% | -49.2% |